Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Immucell (ICCC) Receivables - Net (2016 - 2025)

Immucell's Receivables - Net history spans 16 years, with the latest figure at $3.4 million for Q4 2025.

  • For Q4 2025, Receivables - Net fell 9.34% year-over-year to $3.4 million; the TTM value through Dec 2025 reached $3.4 million, down 9.34%, while the annual FY2025 figure was $3.4 million, 9.34% down from the prior year.
  • Receivables - Net reached $3.4 million in Q4 2025 per ICCC's latest filing, up from $2.6 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $3.8 million in Q4 2024 to a low of $1.4 million in Q2 2022.
  • Average Receivables - Net over 5 years is $2.4 million, with a median of $2.3 million recorded in 2024.
  • Peak YoY movement for Receivables - Net: surged 108.57% in 2021, then tumbled 34.73% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $2.7 million in 2021, then crashed by 34.73% to $1.8 million in 2022, then rose by 24.27% to $2.2 million in 2023, then skyrocketed by 72.56% to $3.8 million in 2024, then dropped by 9.34% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Receivables - Net are $3.4 million (Q4 2025), $2.6 million (Q3 2025), and $2.4 million (Q2 2025).